Related Experiment Videos

[Grover's-like drug eruption under anti-PD-1 therapy for metastatic melanoma]

M Amini-Adle¹, B Balme², S Dalle¹

¹Service de dermatologie, centre hospitalier Lyon-Sud, 165, chemin du grand Revoyet, 69495 Pierre Bénite cedex, France.

Annales De Dermatologie Et De Venereologie

|November 13, 2018

Abstract

No abstract available in PubMed .

Keywords:

Anti PD-1 Dermatose acantholytique Grover Pembrolizumab

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Real-world evaluation of ImmuCare-PRO patient-reported outcomes in melanoma patients treated with immune checkpoint inhibitors.

ESMO real world data and digital oncology·2026

Impact of the COVID-19 pandemic on melanoma: A retrospective study from the French clinical database of melanoma patients (RIC-Mel).

Annales de dermatologie et de venereologie·2025

Synergistic effect between denosumab and immune checkpoint inhibitors (ICI)? A retrospective study of 268 patients with ICI and bone metastases.

Journal of bone oncology·2024

Long term activity of vemurafenib in cancers with BRAF mutations: the ACSE basket study for advanced cancers other than BRAFV600-mutated melanoma.

ESMO open·2023

Lymphomatoid papulosis types D and E: a multicentre series of the French Cutaneous Lymphomas Study Group.

Clinical and experimental dermatology·2021

Renal adverse effects of immune checkpoints inhibitors in clinical practice: ImmuNoTox study.

European journal of cancer (Oxford, England : 1990)·2021

See all related articles